Opinion | Government Race Against a Cure

Canada News News

Opinion | Government Race Against a Cure
Canada Latest News,Canada Headlines
  • 📰 WSJ
  • ⏱ Reading Time:
  • 70 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 63%

From WSJopinion: EU and U.S. trust busters try to stop a biotech merger that has the potential to accelerate genomic cancer testing and save countless lives

Evidence that the coronavirus may have escaped from the Wuhan Institute of Virology catches up to Fauci and other Wuhan Covid deniers, despite suspicious facts that have been apparent from the start. Image: Johannes Eisele/AFP via Getty ImagesCompetition cops in the U.S. and Europe have been stepping up merger scrutiny, which may be warranted in some cases. But now they’re colluding to stop a biotech deal that has the potential to accelerate genomic cancer testing and save countless lives.

The story began in September when San Diego-based Illumina made an $8 billion offer for the four-year-old Silicon Valley startup Grail. Illumina makes platforms that do genetic sequencing for the likes of Covid variants and fetal abnormalities. Grail is Illumina’s prodigal daughter. In 2016 Illumina formed Grail with the goal of developing a blood test that could detect DNA from cancer cells before people show symptoms. A year later Illumina spun off Grail. This let Grail raise venture capital to finance large clinical trials while Illumina focused on building its other businesses.

Fast forward four years. Grail’s technology can now reliably detect 50 cancers at early stages with a simple blood draw. While the tests aren’t 100% accurate, the false positive rate is less than 1%, which is lower than for mammograms and PSA prostate tests. Grail’s technology can also detect the 12 most deadly cancers with 60% accuracy and has the potential to reduce false cancer diagnoses and invasive screenings while increasing early detection of aggressive cancers.

Grail was considering an IPO last fall to raise $100 million when Illumina made a more attractive offer. Illumina says its regulatory expertise can accelerate the commercialization of Grail’s technology. Biotech startups often struggle to obtain regulatory approval and insurance reimbursements.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJ /  🏆 98. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Netanyahu's opponents race to finalize coalition to oust him as deadline loomsNetanyahu's opponents race to finalize coalition to oust him as deadline loomsIsraeli Prime Minister Benjamin Netanyahu’s opponents are racing to seal a coalition government to end his 12-year rule before a midnight deadline.
Read more »

Oakland A's Minor Leaguers Expose 'Fyre Festival' Style Meals, Food Vendor FiredOakland A's Minor Leaguers Expose 'Fyre Festival' Style Meals, Food Vendor FiredThe Oakland A's have FIRED the food vendor responsible for serving its minor league players meals that look WORSE than the Fyre Festival, the team announced.
Read more »

Opinion | Banning Critical Race TheoryOpinion | Banning Critical Race TheoryFrom WSJopinion: The proponents of teaching “systemic racism” are getting a needed lesson in American politics, writes danhenninger
Read more »

FireEye CEO Kevin Mandia On Ransomware: Businesses Must ‘Try To Reduce The Blast Radius’ Of AttacksFireEye CEO Kevin Mandia On Ransomware: Businesses Must ‘Try To Reduce The Blast Radius’ Of AttacksOne of the world’s top cybersecurity experts said even well-defended companies are getting “sucker punched” by ransomware and called on governments to take concerted action against the cybercriminals behind it.
Read more »

FireEye CEO Kevin Mandia On Ransomware: Businesses Must ‘Try To Reduce The Blast Radius’ Of AttacksFireEye CEO Kevin Mandia On Ransomware: Businesses Must ‘Try To Reduce The Blast Radius’ Of AttacksOne of the world’s top cybersecurity experts said even well-defended companies are getting “sucker punched” by ransomware and called on governments to take concerted action against the cybercriminals behind it.
Read more »

Rise in Ransomware Requires Strong Government Response, Executives SayRise in Ransomware Requires Strong Government Response, Executives Say“Pharmaceuticals, hospitals, healthcare, public companies, organizations that don’t have the talent and skills to defend themselves—they’re getting sucker punched,” Kevin Mandia said during the WSJ Pro Cybersecurity Executive Forum.
Read more »



Render Time: 2025-03-13 08:50:50